U.S. Supreme Court Tosses Ruling Against Merck on Fosamax Osteoporosis Drug U.S. Supreme Court Tosses Ruling Against Merck on Fosamax Osteoporosis Drug

The U.S. Supreme Court on Monday threw out a lower court ruling that had revived hundreds of lawsuits accusing Merck& Co of failing to properly warn patients of debilitating thigh-bone fractures as a result of taking its osteoporosis drug Fosamax (alendronic acid).Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Diabetes & Endocrinology News Source Type: news